Optimizing the prophylaxis of hospital-acquired deep vein thrombosis and pulmonary thromboembolism


Cite item

Full Text

Abstract

Aim. To reduce the number of preventable hospital-acquired venous thromboembolic events (HA-VTE) and to improve the quality of VTE prophylaxis at multiprofile hospital. Materials and methods. A comprehensive approach to preventing HA-VTE was developed, which involved the global trigger tool method to assess adverse events, as well as the computerized clinical decision support system (CDSS) to prevent HA-VTE on the basis of relevant clinical practice guidelines, and HA-VTE registry. Results. A total of 50 patients (15 men, 35 women; their median age was 70.5 years) with HA-VTE were included in the HA-VTE registry in January 2014 to June 2015. Assessment of a trend in the prevalence of HA-VTE when introducing CDSS to prevent VTE showed its statistically significant decline in the total number of HA-VTE cases (χ2=7.325, df=1; p=0.0068) and in that of HA-VTE in surgical patients (χ2=7.266, df=1; p=0.0070). The statistical significance of χ2 for linear trend was not achieved for medical patients, which is probably due to the small sample size (χ2=2.764, df=1; p=0.0964). While introducing CDSS, there was a statistically significant reduction in the incidence of postoperative VTE from 8.76 to 4.17 cases per 1000 interventions (χ2=5.347, df=1; p=0.0208; the absolute values of HA-VTE and surgical interventions were used for the calculation). Conclusion. The proposed comprehensive approach can substantially increase the detection rate of HA-VTE and decrease its incidence rates. This requires a personified assessment of the risk of VTE and hemorrhage in all hospitalized patients on day 1 of their admission, timely initiation of recommended VTE prophylaxis, and dynamic assessment of the risk of VTE and hemorrhage for timely correction of the prophylaxis.

About the authors

G I Nazarenko

Медицинский центр Банка России

Москва, Россия

E B Kleymenova

Медицинский центр Банка России

Москва, Россия

S A Payushchik

Медицинский центр Банка России

Москва, Россия

V A Otdelеnov

Медицинский центр Банка России

Москва, Россия

D A Sychev

РМАПО Минздрава России

Москва, Россия

References

  1. Савельев В.С., Чазов Е.И., Гусев Е.И., Кириенко А.И., Акчурин Р.С., Андрияшкин В.В. и др. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология. 2010;4(2):2-37.
  2. US Department of Health and Human Services. The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Washington, DC: US Department of Health and Human Services. 2008. Accessed December 20, 2015. Available at: http://www.ncbi.nlm.nih.gov/books/NBK44178/
  3. Kahn S. Determinants and Time Course of the Postthrombotic Syndrome after Acute Deep Venous Thrombosis. Ann Int Med. 2008;149(10):698. doi: 10.7326/0003-4819-149-10-200811180-00004.
  4. Prandoni P, Kahn S. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol. 2009;145(3):286-295. doi: 10.1111/j.1365-2141.2009.07601.x.
  5. Kyrle P, Rosendaal F, Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet. 2010;376(9757):2032-2039. doi: 10.1016/s0140-6736(10)60962-2.
  6. Министерство здравоохранения Российской Федерации (Минздрав России). Клинические рекомендации (Протокол). Профилактика венозных тромбоэмболических осложнений в акушерстве и гинекологии. Москва; 2014.
  7. Ассоциация онкологов России. Клинические рекомендации по профилактике и лечению тромбоэмболических осложнений у онкологических больных. Москва; 2014.
  8. Снеговой А.В., Елизарова А.Л., Маджуга А.В., Сомонова О.В., Черкасов В.А. Практические рекомендации по профилактике и лечению тромбоэмболических осложнений у онкологических больных. Злокачественные опухоли. 2015;4:399-403.
  9. Falck-Ytter Y. Prevention of VTE in Orthopedic Surgery Patients. Chest. 2012;141(2_suppl):e278S. doi: 10.1378/chest.11-2404
  10. Gould M. Prevention of VTE in Nonorthopedic Surgical Patients. Chest. 2012;141(2_suppl):e227S. doi: 10.1378/chest.11-2297
  11. Kahn S. Prevention of VTE in Nonsurgical Patients. Chest. 2012;141(2_suppl):e195S. doi: 10.1378/chest.11-2296
  12. Lyman G, Bohlke K, Khorana A et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014. J Clin Oncol. 2015;33(6):654-656. doi: 10.1200/jco.2014.59.7351
  13. Cohen A, Tapson V, Bergmann J et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387-394. doi: 10.1016/s0140-6736(08)60202-0
  14. Сулимов В.А., Беленцов С.М., Головина Н.И., Дубровная Н.П., Жидков К.П., Елисеева К.В., Казанчан П.О., Редькин А.В., Родоман Г.В., Фридман И.Л., Шершнев В.Н. Российские данные международного регистра ENDORSE, посвященного выявлению больных с риском тромбоза глубоких вен в стационарах, располагающих возможностями оказания экстренной медицинской помощи. Рациональная фармакотерапия в кардиологии. 2008;3:6-16.
  15. Anderson F, Goldhaber S, Tapson V et al. Improving Practices in US Hospitals to Prevent Venous Thromboembolism: Lessons from ENDORSE. Am J Med. 2010;123(12):1099-1106.e8. doi: 10.1016/j.amjmed.2010.07.011
  16. Allaert F, Benzenine E, Quantin C. More than one in two venous thromboembolism treated in French hospitals occurs during the hospital stays. Phlebology: J Venous Dis. 2015. doi: 10.1177/0268355515575592
  17. Classen D, Resar R, Griffin F et al. ‘Global Trigger Tool’ Shows That Adverse Events In Hospitals May Be Ten Times Greater Than Previously Measured. Health Affairs. 2011;30(4):581-589. doi: 10.1377/hlthaff.2011.0190
  18. Classen D, Lloyd R, Provost L, Griffin F, Resar R. Development and Evaluation of the Institute for Healthcare Improvement Global Trigger Tool. J Patient Safety. 2008;4(3):169-177. doi: 10.1097/pts.0b013e318183a475
  19. Adler L, Denham C, McKeever M et al. Global Trigger Tool. J Patient Safety. 2008;4(4):245-249. doi: 10.1097/pts.0b013e31818e8a87
  20. Назаренко Г.И. , Клейменова Е.Б., Жуйков М.Ю., Пающик С.А., Новакова А.И., Кашевская О.П., Яшина Л.П. Система автоматизации клинических руководств и аудита лечения. Врач и информационные технологии. 2014;2:23-32.
  21. Griffin FA, Resar RK. IHI Global Trigger Tool for Measuring Adverse Events (Second Edition). IHI Innovation Series white paper. Cambridge, MA: Institute for Healthcare Improvement; 2009. (Available on www.IHI.org)
  22. National Coordinating Council for Medication Error Reporting and Prevention. Types of Medication Errors. 2001. Accessed December 20, 2015. Available at: http://www.nccmerp.org/types-medication-errors
  23. Назаренко Г.И., Пающик С.А., Отделёнов В.А., Клеймёнова Е.Б., Яшина Л.П., Сычев Д.А. Оптимизация профилактики венозных тромбозов и эмболий в стационаре с использованием информационных технологий. Рациональная фармакотерапия в кардиологии. 2014;10(4):425-431.
  24. Khanna R, Maynard G, Sadeghi B et al. Incidence of hospital-acquired venous thromboembolic codes in medical patients hospitalized in academic medical centers. J Hosp Med. 2014;9(4):221-225. doi: 10.1002/jhm.2159
  25. Fairbanks R, Caplan S, Panzer R. Integrating usability into development of a clinical decision support system. In: HCI-International 2005. Las Vegas: Mira Digital Pub; 2005.
  26. Maynard G, Stein J. Preventing hospital-acquired venous thromboembolism: A guide for effective quality improvement. Prepared by the Society of Hospital Medicine. AHRQ Publication No.08-0075. Rockville: Agency for Healthcare Research and Quality; 2008.
  27. The Joint Commission. Specifications Manual For National Hospital Inpatient Quality Measures (Version 5.0B). 2015. Accessed December 20, 2015. Available at: http://www.jointcommission.org/specifications_manual_for_national_hospital_inpatient_quality_measures.aspx

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies